Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $240.97 +1.37%
Revenue Growth %: +6.2%
Financial Fact:
Income from operations: 136.25M
Today's EPS Names:
DTGI, CRMT, STZ, More
Revenue Growth %: +6.2%
Financial Fact:
Income from operations: 136.25M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
- Flowserve acquires Trillium valves division for $490 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
